Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

10:00 ET Symic Bio Announces Last Patient Enrolled in SHIELD Trial of SB-030 for Interventions in Peripheral Artery Disease

Symic Bio, a biopharmaceutical company focused on matrix biology that is developing a new category of therapeutics, announced today the completion...


09:00 ET E-QURE's BST Device for Chronic Wound Care Receives Marketing Approval in Israel

- Following receiving CE Marking in Europe, Israel's AMAR is a major milestone for the country where the device was developed -...


08:00 ET Targeting Chemokine Signaling to Overcome Radiation Resistance in Colorectal Cancer

An article published in Experimental Biology and Medicine (Volume 242, Issue 4, February, 2017) identifies a new pathway that renders colon cancers...


08:00 ET DMD Therapeutics Inc. Receives Funding from DMD Foundations to Develop DMD-813 for Treatment of Duchenne Muscular Dystrophy

DMD Therapeutics, Inc., a start-up biotech company, is developing proprietary therapeutics for Duchenne muscular dystrophy (DMD), an orphan disease...


08:00 ET Real-World Data from Boehringer Ingelheim Show Lower Risk of Stroke and Major Bleeding for Pradaxa® (dabigatran etexilate mesylate) Compared to Warfarin

Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from a real-world analysis showing that Pradaxa® (dabigatran etexilate mesylate)...


07:17 ET CHMP Recommends EU Conditional Marketing Authorisation for Natpar® (Parathyroid Hormone) for Patients with Chronic Hypoparathyroidism

This Press Release is intended for Global Use If approved, Natpar would be the first licensed recombinant parathyroid hormone in Europe for the...


06:30 ET VolitionRx Limited's Triage Test Results Validated in Prospective Trial

VolitionRx Limited (NYSE MKT: VNRX) has presented data at the World Congress of GI Endoscopy (ENDO) 2017 conference in Hyderabad, India, from a...


05:52 ET Xynomic Pharma Has Acquired Worldwide Rights of Abexinostat

Xynomic Pharmaceuticals, Inc., an oncology drug research and development company, today announced that it has acquired exclusive worldwide rights...


Feb 23, 2017, 18:42 ET LA Fitness Hosts Fundraiser, Action For ALS, To Help Find A Cure For Lou Gehrig's Disease

In support of Augie's Quest, LA Fitness announced plans to host its seventh annual in-club event, Action for ALS, across the company's over 690...


Feb 23, 2017, 18:40 ET New Assay May Lead to a Cure for Debilitating Inflammatory Joint Disease

Current treatments for rheumatoid arthritis relieve the inflammation that leads to joint destruction, but the immunologic defect that...


Feb 23, 2017, 16:22 ET People with Epilepsy: Tell Us About Rare Risk of Death

People with epilepsy want their health care providers to tell them about a rare risk of death associated with the disorder, according to a...


Feb 23, 2017, 13:56 ET At Cardiology 2017 Conference, Experts in Congenital Heart Disease in Children and Adults Will Discuss Cutting-Edge Healthcare in a Cost-Conscious World

Pediatric heart care spans from the earliest point of fetal gestation to early adulthood, which means a whole new generation of children with...


Feb 23, 2017, 11:30 ET OncoSec Announces Positive Phase II Data Demonstrating Company's ImmunoPulse® IL-12 in Combination with Pembrolizumab Increased Response Rates in Anti-PD-1 Non-Responder Melanoma Patients

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today reported new...


Feb 23, 2017, 10:46 ET Imanis Life Sciences Launches Line of Oncolytic Vaccinia Viruses Encoding Reporter Genes From Genelux Corporation

Imanis Life Sciences announced today the launch of a new product line of oncolytic vaccinia viruses for virotherapy research. These viruses are...


Feb 23, 2017, 10:30 ET PPAHS Releases Position on Ambulation as Key Health Metric

The Physician-Patient Alliance for Health & Safety (PPAHS) has released a position paper calling for patient ambulation as a key health metric...


Feb 23, 2017, 09:00 ET New study of antibiotic use on farms and antibiotic resistant Salmonella pathogens shows the need for more robust farm to fork research

A team of interdisciplinary scientists at the Medical University of South Carolina and the Charleston VA Medical Center Research Service recently...


Feb 23, 2017, 09:00 ET U.S. FDA Approves Increase in Number of Clinical Sites for E-QURE’s Pivotal Trial of BST Device for the Treatment of Chronic Wound Care

Could potentially shorten study period by more than six months E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of...


Feb 23, 2017, 08:30 ET MabVax Therapeutics Announces FDA Authorization to Proceed with MVT-1075 in a Phase I Clinical Trial for the Treatment of Pancreatic Cancer

MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage oncology drug development company, announces that it has received notice from...


Feb 23, 2017, 08:01 ET Tocagen Achieves Key Development Milestone for Lead Product: Phase 2 Randomized Trial in Patients with Recurrent Brain Cancer Fully Enrolled

Tocagen Inc., a clinical-stage, cancer-selective gene therapy company, today announced it has completed patient enrollment in the Phase 2 portion...


Feb 23, 2017, 07:11 ET Improved reversals of cognitive decline in Alzheimer's Disease

The inventor and developer of the original MEND protocol (metabolic enhancement for neurodegeneration), Dr. Dale Bredesen, has developed a more...


Feb 23, 2017, 07:00 ET BioLight's TeaRx Multi-Parameter Diagnostic Assays to be Used in Dry Eye Syndrome Drug Trial

BioLight Life Sciences Ltd. (TASE: BOLT) ("BioLight"), an emerging global ophthalmic company focused on the discovery, development and...


Feb 23, 2017, 06:58 ET Leading Gastroenterologists Agree That Diagnosing And Managing Irritable Bowel Syndrome (IBS) In Patients With IBS-M (Mixed Diarrhea And Constipation) Remains A Challenging And Difficult To Treat Medical Condition

Gastroenterologists across the nation are looking for options to treat their patients with irritable bowel syndrome (IBS), especially those who...


Feb 23, 2017, 04:11 ET New England Journal of Medicine Publishes Phase 1b Results for Shire's Investigational Treatment for Hereditary Angioedema, a Rare Genetic Disease

Results Served as Basis for Ongoing Phase 3 Trial Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in rare diseases, today announced the...


Feb 22, 2017, 12:35 ET New Freespira® Study Shows Nearly 80% of Patients are Panic Attack Free at One Year Post-Treatment

Palo Alto Health Sciences, Inc. (PAHS), developer of the Freespira® at-home treatment for panic attacks and other symptoms of panic...


Feb 22, 2017, 09:27 ET MedAvante Names Ropacki Head of Research and Development

MedAvante, Inc., the leading global clinical data services company dedicated to maximizing signal detection in clinical trials, announced that...